Search

HRSA Countermeasures Injury Compensation Program Information Collection Revision

The Health Resources and Services Administration (HRSA) has submitted a revised Information Collection Request (ICR) for the Countermeasures Injury Compensation Program (CICP) to the Office of Management and Budget (OMB) for approval. This notice requests public comments on the revisions, which aim to improve efficiency and data quality.

AMA Applauds Bill Exempting Physicians from H-1B Visa Fee

The American Medical Association (AMA) is applauding the introduction of bipartisan legislation that would exempt physicians and other health care professionals from a $100,000 filing fee on new H-1B visa petitions. This action aims to alleviate costs for hiring medical professionals and address physician shortages.

FDA Consultation on i-Health Inc. Culturelle Gummies

The FDA has opened a comment period regarding i-Health Inc.'s Culturelle Women's Probiotic + Multivitamin Gummies. This consultation seeks public input on the product, with specific details available via the provided link.

FDA: L-Theanine Powder Supports Relaxation Claim

The FDA has received a submission regarding L-Theanine Powder, specifically from Threshold Enterprises (Source Naturals), for its product that claims to support relaxation and ease everyday stress. This notice indicates a submission for a dietary supplement claim.

FDA Variance Application from Alpha-Omega Services

The FDA has received a variance application from Alpha-Omega Services, Inc. The application pertains to medical device regulations. Further details are available via the provided URL.

FDA Complaint Document

The FDA has posted a complaint document related to FDA-2026-H-2311-0001. The document is available for review on the Regs.gov platform. No further details on the nature of the complaint or its implications are provided.

FDA GRAS Notice 1288 Amendment for Steviol Glycosides

The FDA has posted an amendment to GRAS Notice 1288 concerning enzyme-modified steviol glycosides. This notice is from the manufacturer and is part of the Generally Recognized As Safe (GRAS) notification process.

FDA CDER Response Letter to Hyman, Phelps & McNamara

The FDA's Center for Drug Evaluation and Research (CDER) has posted a response letter addressed to the law firm Hyman, Phelps & McNamara, P.C. The document was made available on March 17, 2025, through the Regs.gov portal. No other details regarding the content of the response are provided.

FDA Closes Comment Period for Blueroot Health Nutrient Submission

The FDA has closed the public comment period for a nutrient submission from Blueroot Health concerning their B6 + B Complex product. The submission was related to energy metabolism support. No further action is required from the public at this time.

FDA Document on GreenBio Nutrients Joint Health Capsules

The FDA has posted a document related to GreenBio Nutrients Inc.'s ILEXPOWER and JointAlive Capsules. The document is available for review on the Regs.gov platform. No specific regulatory action or compliance requirement is detailed in the provided information.